Abstract
Human platelets are released from the cytoplasm of megakaryocytes and average 2-3 μm in diameter. In response to vascular injury, platelets stick together like glue, seal the wounded area, and dispense their contents into the nearby milieu. Taken at face value, these features and functions seem simplistic and unrefined. As one digs deeper, however, it becomes apparent that platelets are intricately wired and created for multifunctional purposes. One of their duties, which cropped up over the last decade, is to synthesize proteins both continually and on demand. It turns out that platelets possess thousands of template mRNAs, ribosomes, and requisite translational machinery that they use to generate new proteins. Platelets also retain tools that grant them the ability to process precursor mRNAs and microRNAs. In this review, we briefly describe what we currently know about protein synthesis in platelets, its functional significance, and where the field is likely to take us over the next decade.
Keywords: mRNA, platelets, protein synthesis, ribosomes, splicing, translation, synthetic pathways, megakaryocytes, thrombopoiesis, mechanisms, Leukocytes, glycoprotein
Current Proteomics
Title: Platelet Protein Synthesis and Translational Control
Volume: 8 Issue: 3
Author(s): Robert A. Campbell, Neal D. Tolley, Hansjorg Schwertz and Andrew S. Weyrich
Affiliation:
Keywords: mRNA, platelets, protein synthesis, ribosomes, splicing, translation, synthetic pathways, megakaryocytes, thrombopoiesis, mechanisms, Leukocytes, glycoprotein
Abstract: Human platelets are released from the cytoplasm of megakaryocytes and average 2-3 μm in diameter. In response to vascular injury, platelets stick together like glue, seal the wounded area, and dispense their contents into the nearby milieu. Taken at face value, these features and functions seem simplistic and unrefined. As one digs deeper, however, it becomes apparent that platelets are intricately wired and created for multifunctional purposes. One of their duties, which cropped up over the last decade, is to synthesize proteins both continually and on demand. It turns out that platelets possess thousands of template mRNAs, ribosomes, and requisite translational machinery that they use to generate new proteins. Platelets also retain tools that grant them the ability to process precursor mRNAs and microRNAs. In this review, we briefly describe what we currently know about protein synthesis in platelets, its functional significance, and where the field is likely to take us over the next decade.
Export Options
About this article
Cite this article as:
A. Campbell Robert, D. Tolley Neal, Schwertz Hansjorg and S. Weyrich Andrew, Platelet Protein Synthesis and Translational Control, Current Proteomics 2011; 8 (3) . https://dx.doi.org/10.2174/157016411797247521
DOI https://dx.doi.org/10.2174/157016411797247521 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biomarkers for Systemic Therapy in Ovarian Cancer
Current Cancer Drug Targets Kavalactone Pharmacophores for Major Cellular Drug Targets
Mini-Reviews in Medicinal Chemistry Subject Index To Volume 12
Current Pharmaceutical Design Rheumatoid Arthritis: A Clinical Overview of New Diagnostic and Treatment Approaches
Current Topics in Medicinal Chemistry Inflammation and Cancer: When NF-κB Amalgamates the Perilous Partnership
Current Cancer Drug Targets Neurological Involvement in Rheumatoid Arthritis
Current Immunology Reviews (Discontinued) Cancer Stem Cells: Current Status and Therapeutic Implications in Cancer Therapy-A New Paradigm
Current Stem Cell Research & Therapy In Vitro and In Vivo Models for Analysis of Resistance to Anticancer Molecular Therapies
Current Medicinal Chemistry Advanced Cardiac Imaging of Radiation-induced Injury - a Review
Current Medical Imaging A Common Pathway for All Autoimmune Diseases? The Unholy Alliance of Environment, Cell Death and Nucleic Acids
Current Immunology Reviews (Discontinued) Mechanisms of Drug-Induced Mitotic Catastrophe in Cancer Cells
Current Pharmaceutical Design An Overview on Keratinocyte Growth Factor: From the Molecular Properties to Clinical Applications
Protein & Peptide Letters Drug-Loaded Nanocarriers in Tumor Targeted Drug Delivery
Current Biotechnology Predictive Efficacy Biomarkers of Programmed Cell Death 1/Programmed Cell Death 1 Ligand Blockade Therapy
Recent Patents on Anti-Cancer Drug Discovery Biologic Therapy in Inflammatory and Immunomediated Arthritis: Safety Profile
Current Drug Safety Natural Products Based Anticancer Agents
Mini-Reviews in Organic Chemistry Substance Abuse, HIV-1 and Hepatitis
Current HIV Research Targeting CCK Receptors in Human Cancers
Current Topics in Medicinal Chemistry Microfilament Actin Remodeling as a Potential Target for Cancer Drug Development
Current Cancer Drug Targets Epigenomics
Current Drug Metabolism